Transmissible spongiform encephalopathies (TSE) (e.g., prion disease and scrapie) are progressive, fatal neurodegenerative diseases of humans and other animals (10, 34) . The hallmark of TSE diseases is the conversion of normal prion protein (PrP c ) to an abnormal, protease-resistant form (PrP sc ). Characteristic features are spongiosis, astrocytosis, and neuronal loss in the central nervous system (CNS). Of the many enigmas concerning this process, three stand out. First, how is TSE inheritable information encoded and transmitted in PrP in the absence of discernible nucleic acids; second, what are the pathophysiologic events by which PrP sc causes CNS disease; and third, why is there no detectable immune response accompanying scrapie infection (4, 5) ? In this report, we use a model of scrapie in mice to focus on the pathophysiologic response in the CNS and on the immune response.
Within the brain, TSE disease generates an accumulation of protease-resistant proteins, PrP sc or PrP res , derived by a posttranslational event from a normal host-encoded protease-sensitive isoform, designated PrP c or PrP sen (10, 34) . PrP c is attached by a glycolipid anchor to the cell surface. In the CNS, PrP c converts to PrP sc in both neurons and astrocytes (10, 13) . In genetic experiments with PrP knockout (PrP Ϫ/Ϫ ) mice, hamster PrP c was expressed only in neurons after using a neuron-specific enolase promoter (35) or in astrocytes upon using an astrocyte-specific glial fibrillary astrocyte protein (GFAP) promoter (37) . In both instances, challenge with hamster scrapie resulted in TSE, thereby incriminating both neurons and astrocytes in the replication of PrP sc and in the disease process. Still unclear are how PrP c converts to PrP sc in these cells and how PrP sc accumulation gives rise to the profound neurodegeneration characteristic of scrapie.
Associated with ongoing TSE disease is the expression of tumor necrosis factor-alpha (TNF-␣), interleukin-1 alpha (IL-1␣), IL-1␤, GFAP, and murine acute-phase response gene mRNA in the brain but not in peripheral tissues like spleen, kidneys, or liver (9) . Absent or not altered in the TSE brains are IL-4, IL-5, gamma interferon (IFN-␥), IL-2, IL-6, and IL-3 mRNA (9) . In addition to these cytokines, chemokines are present within and outside the CNS, where they function as soluble mediators possessing a spectrum of actions and chemotactic activities (3, 39, 46) . Localized production of chemokines is possible from astrocytes and neurons, the two CNS cell types involved in conversion of PrP c to PrP sc . Yet expression of chemokines in the CNS during scrapie infection is unknown.
In this work, we evaluated the expression of chemokines as well as the presence of a cellular T-cell immune response in TSE. For that purpose, we studied scrapie-infected mice for the expression of multiple chemokine genes, infiltration of T lymphocytes, and presence of major histocompatibility complex (MHC) molecules throughout the progression of TSE. We found that IFN-␥-inducible protein 10 (IP-10), macrophage inflammatory protein 1␣ (MIP-1␣), RANTES, and to a lesser extent MIP-1␤ mRNA were enhanced but not those of other chemokine molecules. We also noted T-cell infiltration into the parenchyma of the brains from scrapie-infected mice and in five of six patients with clinical, neuropathologic, and biochemically defined Creutzfeldt-Jakob disease (CJD). Tetramer analysis of T cells from scrapie-infected mice suggests that such T cells may be specific to MHC-restricted prion peptides but incapable of lytic responses or PrP peptide-stimulated IFN-␥ and TNF-␣ production. Biosystems) by the solid-phase method using 9-fluorenylmethoxy carbonyl chemistry, purified by high-pressure liquid chromatography on an RP3000-C 8 reversephase column, and identified by electrospray mass spectrometry (23) . In addition, overlapping 15-mer peptides (see Table 3 ) that covered the mouse PrP (mPrP) sequence were purchased from Multiple Peptide Systems, San Diego, Calif.
Binding studies. Peptide-MHC binding affinity was determined by measuring up-regulation of MHC molecule expression at the cell surface (MHC stabilization) induced by peptide added exogenously. The mutant cell line, in which transport of endogenous peptides to the endoplasmic reticulum is deficient, (11, 23) . Briefly, cells (5 ϫ 10 5 /well) were incubated at 37°C in microtiter plates in the presence of increasing peptide concentrations (10 Ϫ10 to 10 Ϫ5 M). The expression of peptide-stabilized MHC molecules was analyzed after a 4-h incubation period. Cells were incubated on ice for 1 h with 0.1 ml of hybridoma culture supernatant of mouse monoclonal antibody 28-14-8S (antiDb, anti-Ld), Y3 (anti-Kb), or SF1-1.1.1 (anti-K d ). As negative controls, the cells were cultured in medium alone. After being washed once with ice-cold 1% bovine serum albumin-PBS and incubated for 1 h with the fluorescent secondary antibody (fluorescein isothiocyanate [FITC]-conjugated goat anti-mouse immunoglobulin G [IgG] ), the cells were washed twice and fixed in 1% paraformaldehyde in 1% bovine serum albumin-PBS. Analysis followed in a fluorescenceactivated cell sorter (FACScan; Becton Dickinson, San Jose, Calif. Cytotoxic T-cell assay. mPrP peptides at a concentration of 20 g/ml were incubated with PrP Ϫ/Ϫ MEF labeled with 51 chromium (15, 40, 45) . Lymphocytes harvested from the brain (15) and spleen (40, 45) were added at effector-totarget cell ratios of 100:1, 50:1, and 25:1 for a 5-h assay as described elsewhere (15, 40, 45) . As a positive control, PrP Ϫ/Ϫ MEF were infected with LCMV (multiplicity of infection, 1.0) for 48 h and added to lymphocytes harvested from scrapie-infected mice or from LCMV-infected mice as described elsewhere (15, 40, 45) .
MHC class I tetramers. K b -restricted mPrP amino acids (aa) 2 to 9, aa 152 to 160, and aa 232 to 241; D b -restricted LCMV GP aa 33 to 41; D b -restricted LCMV NP aa 396 to 404; and K b -restricted LCMV GP aa 34 to 43 were used as allophycocyanin or phycoerythrin conjugates. Either these were obtained from the Tetramer Core Facility, Emory University, Atlanta, Ga. (1), or in some instances, biotinylated MHC-peptide monomers were made as tetramers in our laboratory (21) immediately before use. Staining with MHC class I tetramers was performed at a 1:50 to 1:100 dilution in the presence of various surface antibodies for 30 min at 4°C, and propidium iodide was added at a final concentration of 5 g/ml to allow analytical exclusion of dead cells (21) .
Flow cytometry and cytokine ELISPOT. Single-cell suspensions of lymphocytes were restimulated for 5 h with MHC class I-or class II-restricted peptides (1 or 2 g/ml, respectively) in the presence of recombinant human IL-2 (10 to 50 U/ml; PharMingen, La Jolla, Calif.) and brefeldin A (1 g/ml; Sigma, St. Louis, Mo.). Staining for cell surface antigen and intracellular antigens was performed as described previously (21) . Negative controls were peptide-stimulated cells obtained from uninfected mice, cells restimulated for 5 h in the absence of viral peptides, and cells stained with conjugated cytokine-specific antibodies preincubated for 30 min at 4°C with an excess of recombinant cytokine. Cells were acquired with FACSort or FACSCalibur flow cytometers (Becton Dickinson) using Cell Quest software (Becton Dickinson). For five-and six-color analyses, a FACSVantage SE flow cytometer (Becton Dickinson) was used. FITC-, phycoerythrin-, CyChrome-, peridinin chlorophyll-a protein-, or allophycocyanin-conjugated, biotinylated, and/or purified antibodies (PharMingen) were used to evaluate CD4 (RM4-5) and CD8a (53-6.7) cells and evaluated as described elsewhere (21, 40, 45) .
Immunohistochemical staining of CNS tissues. Brains removed from test mice were covered with Tissue-Tec OCT (Miles Diagnostics Division, Elkhart, Ind.), snap-frozen at Ϫ80°C in isopentane, and then stored at Ϫ20°C. Immunohistochemistry was performed on 6-to 10-m-thick cryostat sections that were fixed in 100% ethanol for 15 min at 4°C and blocked with avidin and biotin (Vector Laboratories, Burlingame, Calif.). Staining was done with the following primary antibodies: anti-CD8 (anti-Ly-2 and Ly-3; PharMingen), anti-CD4 (anti-L3T4; PharMingen), anti-H-2 monotypic antigen (MHC class I), anti-Ia antigen (MHC class II), anti-B220 (Boehringer Mannheim, Indianapolis, Ind.), and anti-F4/80 (Serotec, Oxford, England). The second antibody was either a biotinylated antimouse IgG used in conjunction with the Vectastain Elite ABC (peroxidase) kit (Vector Laboratories) or anti-Ig-FITC. In the former case, staining was detected using diaminobenzidine as a chromogen. Sections were counterstained in Mayer's hematoxylin (Sigma) and mounted in Aqua-Mount (Lerner Laboratories, Pittsburgh, Pa.).
For light microscopy study, brain tissue was fixed in Bouin's fixative or 10% formaldehyde, prepared in paraffin, sectioned, and stained with hematoxylin and eosin.
RESULTS

Presence of CD8 and CD4 T cells in brains of scrapieinoculated PrP
؉/؉ but not PrP ؊/؊ mice. Twelve weeks after i.c. injection of 100,000 infectious doses of Chandler strain mouse scrapie into 6-to 8-week-old C57BL/6 and BALB mice, both CD8 and CD4 T cells infiltrated the brain parenchyma, including regions of the hippocampus, cortex, and cerebellum ( Fig. 1A and B ). These cells were easily discernible by immunochemical staining of brain sections with monoclonal antibodies to CD4 and CD8 T cells (15) (four to six mice per group; experiment repeated twice). Such infiltration rarely was perivascular, and it was not appreciated by light microscopy. No infiltration was seen at 6 or 10 weeks after inoculation of PrP ϩ/ϩ mice or at any time in mice injected with PrP Ϫ/Ϫ (Table 1) . Correspondingly, oral inoculation of 100,000 infectious doses of mouse scrapie into 8-week-old C57BL/6 mice led to classic clinical and histopathologic disease with conversion of PrP c to PrP sc in the CNS within 282 to 300 days. All six of these mice had CD8
ϩ and CD4 ϩ T-cell infiltrates as did all four murine recipients of 100,000 infectious doses at 185 days after i.p. inoculation. To the contrary, age-matched control mice not injected with scrapie had no CD8 or CD4 T cells in their brains (group of four mice), nor did brains from mice given scrapie orally contain either PrP sc or infiltrating CD8 ϩ or CD4 ϩ T cells 100 days after administration. Other immunochemical analysis revealed a close temporal association of T-cell infiltration with the expression of MHC molecules, especially class I, and the presence of F4/80 ϩ microglia or macrophages. Enhanced expression of MHC transcripts after scrapie infection was noted previously by Duguid and Trzepacz (14) . Apoptosis of neurons lagged behind the detection of T cells. All these studies included stringent controls for antibody specificity and infection of CNS tissues (15, 22, 32) . RNase protection assay (RPA) analysis (2, 9) displayed in Fig. 2 shows elevations of the T-cell chemokines-most prominently MIP-1␤, IP-10, and RANTES-in C57BL/6 and BALB/c mice with the macrophage chemokine C10 upregulated in brains of C57BL/6 but only minimally so in brains of BALB/c mice. MIP-2 was also enhanced in most mice during scrapie infection in the brain at 18 weeks and in a few infected mice at 6 weeks post-scrapie inoculation (Fig. 2) . Other chemokines such as monocyte chemotactic protein 3 and TCA-3 were not elevated at any time point at either tissue site.
FIG. 1. (A and B) CD8
ϩ T-cell infiltration in the parenchyma of a C57BL/6 (A) and BALB/WEHI (B) mouse 18 weeks after i.c. inoculation with scrapie. (C and D) Micrographs of sections of autopsied CNS from two distinct patients with CJD stained with antibody to human T cells. In these human tissues, T cells most often lay near blood vessels but occasionally appeared in the brain parenchyma. T-cell infiltration in humans with TSE disease. Six brains from well-studied CJD patients were reevaluated for T-cell infiltration. As before, no T-cell infiltration was apparent by light microscopy. However, the application of antibody to human CD3 showed that T cells accumulated predominantly near or around blood vessels but also in the CNS parenchyma in five of the six brains studied. Shown in 
Binding of K b tetramers to lymphocytes harvested from scrapie-inoculated PrP
؉/؉ mice. K b tetramers containing either mPrP aa 2 to 9, aa 152 to 160, or aa 232 to 241 were made (1) and showed low to modest but consistent binding to splenic lymphocytes at day 7 (data not shown) and days 50 and 71 (Fig.  3) after scrapie inoculation. Similar inoculation into PrP Ϫ/Ϫ mice gave lower levels (background) of lymphocyte binding to K b tetramers at day 7 (data not shown) and days 50 and 71 post-scrapie infection (Fig. 3 , data shown for three mice). On day 50, the mean lymphocyte-K b tetramer binding values Ϯ1 standard error were these: for aa 2 to 9, that for PrP ϩ/ϩ mice was 2.1 Ϯ 0. tetramer binding to splenic lymphocytes harvested from PrP ϩ/ϩ mice 7 days after scrapie inoculation were as follows: for aa 2 to 9, 2.6 Ϯ 0.3; for aa152 to 160, 2.1 Ϯ 0.3; and for aa 232 to 246, 1.2 Ϯ 0.08 (three mice per group). Binding by K b tetramers to lymphocytes from PrP Ϫ/Ϫ mice (three mice per group) 7 days after scrapie infection showed background values 30 to 50% lower than those to lymphocytes from PrP ϩ/ϩ mice. Thus, binding values for each of these three K b tetramers to splenic lymphocytes from scrapie-free C57BL/6 mice were 0.6 Ϯ 0.8 or less at days 7, 50, or 71 of exposure. Because the K b mPrP tetramers are relatively unstable, they were used within 2 to 3 weeks of labeling or made fresh preceding each experiment. Lymphocytes obtained from brains of mice 12 to 18 weeks after scrapie infection failed to bind to K b tetramers, and other tetramers made to detect LCMV-specific CD8 ϩ T cells (1, 21) failed to stain splenic lymphocytes from PrP 
Effector function(s) of lymphocytes obtained from scrapieinoculated PrP
؉/؉ mice. Next we examined whether CD4 or CD8 T cells infiltrating the CNS and the enhanced MHC expression contributed to the pathogenesis of scrapie. For these studies we employed several groups of mice made genetically deficient to CD4, CD8, MHC class I, or MHC class II molecules. However, deletion of CD4 or CD8 T cells did not significantly decrease the kinetics or incidence of developing scrapie, as shown in Table 2 and in agreement with a report by Klein et al. (24) . Mice null for CD4 and CD8 T cells died or showed severe morbidity at 156 Ϯ 8 or 154 Ϯ 8 days (mean Ϯ 1 standard error), respectively, compared to 148 Ϯ 8 days for CD4 and CD8 T-cell-competent mice. Similarly, MHC class I and class II knockout mice developed severe disease at days 165 Ϯ 5 or 158 Ϯ 7, respectively, incubation periods similar to those of genetically normal mice. However, mice lacking both CD4 and CD8 T cells took 193 Ϯ 5 days to show signs of clinical scrapie infection, a significantly longer period (P Ͻ 0.01) than that observed for wild-type mice or those lacking only one component, i.e., CD4 Ϫ/Ϫ , CD8 Ϫ/Ϫ , MHC class I Ϫ/Ϫ , or MHC class II Ϫ/Ϫ alone. These data were confirmed in a repeat experiment. In the limited number of MHC class I and MHC class II double-knockout mice available (total of four receiving i.c. and three receiving i.p. inoculations of scrapie) also showed prolonged incubation periods for developing clinical disease, taking longer than single-knockout MHC I or MHC II mice. All mice inoculated i.c. took at least 204 days to become moribund, and mice inoculated i.p. became clinically ill at or after 254 days. Within 8 days of becoming ill, all these MHC double-knockout mice died or were sacrificed because of severe morbidity, and neuropathologic and biochemical evidence of scrapie infection was found.
The final studies evaluated the effector functions of lymphocytes from scrapie-infected mice. Initially, lymphocytes were harvested from C57BL/6 or BALB/WEHI mice at 7, 14, 51, 70, or 150 days after primary inoculation of 100,000 PFU of scrapie or after two or three inoculations given i.p. 3 weeks apart. These splenic lymphocytes were then cultured with 51 Crlabeled PrP Ϫ/Ϫ MEF or, from PrP Ϫ/Ϫ mice, macrophages coated with the relevant K b -restricted aa 2 to 9, aa 152 to 160, or aa 232 to 241 or L d -restricted aa 100 to 108 prion peptidepeptide PrP Ϫ/Ϫ cells. No specific 51 Cr release indicative of CTL activity was seen, although when lymphocytes originating from syngeneic mice infected 7 days earlier with LCMV were added to PrP Ϫ/Ϫ targets either infected with LCMV or coated with relevant LCMV peptide, significant lysis occurred (Fig.  5A) . Similar negative results occurred with lymphocytes harvested from brains of scrapie-infected mice, whereas lymphocytes harvested from LCMV-infected mice (15) lysed syngeneic LCMV-infected targets. In subsequent experiments, lymphocytes were harvested on days 7, 50, or 71 after PrP ϩ/ϩ mice were infected with scrapie, and mPrP aa 2 to 9, aa 152 to 160, and aa 232 to 241 failed to induce cytoplasmic expression of IFN-␥ or TNF-␣ (data not shown) (8, 21, 29) , although again expression of those cytokines was easily induced in mice at days 7, 50, or 120 after LCMV infection when their splenic lymphocytes were similarly incubated with relevant LCMV K b , D b , or L d peptides (21, 40) . In addition, neither IL-2, IL-6, nor IL-10 expression was induced in lymphocytes harvested from PrP ϩ/ϩ mice at similar times after scrapie infection and incubation with mPrP aa 2 to 9, aa 152 to 160, or aa 232 to 241, (11), and the negative control is the PB1 peptide VSDGGPNLY (12) . For binding, the horizontal axis of the graph shows the reciprocal log peptide dilution, while the vertical axis reflects the mean fluorescence intensity. although IL-4, IL-6, and IL-10 were expressed in lymphocytes after LCMV infection (21, 40, 44) .
Next, as shown in Table 3 , we obtained 15-mer overlapping peptides of mPrP and arranged them in 14 groups for testing against splenic lymphocytes from scrapie-inoculated PrP ϩ/ϩ mice. After one or three i.p. inoculations of 100,000 infectious doses of Chandler scrapie, each spaced 3 weeks apart, spleens were harvested, and single-cell suspensions of lymphocytes made and incubated with the various mPrP cocktails displayed in Table 3 and then stained and fixed to allow detection of intracellular cytokines IFN-␥ and TNF-␣ as well as molecules bound to CD4 or CD8 T cells. Although the accompanying control splenocytes from LCMV-immunized mice concurrently tested but with appropriate LCMV peptides gave positive results, we were unable to detect any convincing intracellular expression of IFN-␥ (Fig. 5B) or TNF-␥ (data not shown) in either CD8 or CD4 T cells from scrapie-inoculated mice. Notably, similar inoculation of murine scrapie into PrP Ϫ/Ϫ mice, due to a deletion of mPrP, also failed to reveal IFN-␥ or TNF-␣ cytoplasmic expression in CD8 or CD4 T lymphocytes. Further, such lymphocytes from scrapie-infected PrP ϩ/ϩ or PrP Ϫ/Ϫ mice failed to lyse syngeneic PrP Ϫ/Ϫ 51 Cr-labeled MEF coated with the peptide cocktails (Fig. 5 ).
DISCUSSION
We found T cells in brains of mice and humans with TSE. Our kinetic studies, possible in the murine PrP ϩ/ϩ model using the Chandler RML scrapie strain, located both CD4 and CD8 T cells within the brain by 12 weeks (84 days) and later after i.c. 3 ). In contrast, T cells harvested from littermates primed seven days (P o ) earlier with LCMV ARM 10 5 PFU i.p. or 60 days after initial priming receiving a second injection of LCMV ARM (S o ) lyse these PrP Ϫ/Ϫ target cells when they were infected with LCMV ARM 2 days earlier or coated with 20 g of the LCMV GP peptide aa 33 to 41. See Materials and Methods and reference 21 for details of 51 Cr-release assay and immunizations. Abbreviations: ko, knockout; CTL, cytotoxic T lymphocyte; E:T, effector-to-target cell; INF, infected; ND, not determined; spl, spleen; 3 ϫ inoc, inoculated three times. (B) T cells obtained after multiple (three) inoculations with scrapie fail to generate intracytoplasmic IFN-␥ when stimulated with the various pools of peptides that cover the mPrP sequence (see Table 3 challenge, at 185 days after i.p. administration, and at 282 to 300 days after oral inoculation. No such infiltration of T lymphocytes followed similar inoculations of murine scrapie into PrP Ϫ/Ϫ mice or into uninoculated control mice. Nor did T cells appear in the brain or at 6 or 10 weeks after i.c. challenge or 100 days after oral inoculation of PrP ϩ/ϩ mice. These results agree with those of Betmouni et al. (6, 7) who reported Tlymphocyte recruitment and microglia activation after i.c. inoculation of the ME7 strain of scrapie long before onset of clinical disease. In contrast to our studies, in which infiltrating T cells were not found in the brain 8 weeks after RML Chandler scrapie inoculation, these authors (6, 7) found T-cell infiltrates at that time but used a different strain of mouse scrapie.
Since only activated T cells are believed to cross the bloodbrain barrier to enter the CNS, presumably scrapie infection was responsible for the initial T-cell activation. The cause could be generation of antigen-specific scrapie T cells or, alternatively or concomitantly, chemokine and cytokine chemoattractants induced during scrapie infection in the brain. We (20) and others (reviewed in references 3, 39, and 46) have incited cytokine and chemokine expression focally in selected tissues using transgenic approaches with cell-specific promoters and reported the resulting infiltration of lymphocytes into the target area. Our studies here are unable to discriminate between these two possibilities at present. The detection here of suspected PrP ϩ/ϩ antigen-specific T cells by tetramers, but at low levels, was not associated with intracellular cytokine expression when such lymphocytes were incubated with the appropriate prion peptide(s). This finding is in accord with those of Zajac et al. (47) , who reported an example of disassociation between tetramer-positive staining and intracellular cytokine staining in a viral model, while Field and Shenton (16) previously reported peripheral lymphocyte sensitization with TSE infection.
After entering the brain, activated T cells remain for approximately 10 to 14 days and then circulate out unless the recognition T-cell antigen appears expressed in the CNS milieu or appropriate chemokines are continuously present (15, 18) . Although the presence of CD8 ϩ and CD4 ϩ T cells and scrapie infection in the CNS bear a direct association, the lack of marked inflammatory cell recruitment to that site, coupled with the failure of T cells obtained from the periphery and the CNS to display detectable effector functions in vitro as cytotoxicity or expression or release of Th1 cytokines, suggests that these cells are minimally or not at all significant to the disease process. In agreement are earlier studies in which several immunosuppressive strategies or separate deletion of either CD4 or CD8 T cells did not alter the kinetics or outcome of scrapie infection (reviewed in references 4, 5, and 24). Further, the Th1 cytokine IFN-␥ was not found in brains of mice succumbing to scrapie infection (9) . However, as shown here, deletion of both CD4 and CD8 T cells significantly delayed the onset of disease, although once disease occurred, it was uniformly fatal. Hence, the delayed progression of disease and expression of TNF-␣ in brains of scrapie-infected mice (9) raise the possibility that the T-cell response may modestly influence the infection.
Why is it difficult to detect prion-specific T-cell response with scrapie infection? Arguments (reviewed in references 4 a Peptides comprising pools 1 through 14 were incubated at a concentration of 20 g/ml for 5 h with a single-cell suspension of lymphocytes obtained from spleens of mice inoculated three times with murine scrapie (see Materials and Methods and reference 21) in the presence of recombinant IL-2 (10 to 50 U/ml) and brefeldin A (1 g/ml) and stained with antibodies to either CD4 or CD8 and with antibody to IFN-␥ conjugated to a difference fluorochrome. Cells were studied by fluorescenceactivated cell sorting using two-color analysis (see Fig. 5 ). and 5) to explain such a phenomenon range from proposing a state of tolerance due to identical amino acid sequences between PrP c and PrP sc that is not broken either by scrapie infection or immunization with scrapie prions injected in adjuvant and the unusual protease resistance of PrP sc , which might prevent its degradation and processing in antigen-presenting cells. Yet, immune responses are reproducibly generated against other "self antigens" when the self protein or one of its peptide fragments is inoculated with adjuvants or during infections. For example, immune responses to CNS proteins like myelin basic protein, proteolipid protein of myelin, and myelin-associated oligodendrocyte basic protein, etc., are easily generated and often associated with corresponding autoimmune diseases (17, 19, 28, 48) . Further, specific antiviral immune responses can be detected against endogenous murine retroviruses (31) that have existed in their hosts over thousands of years, most often infecting thymi and peripheral lymph nodes. Heterologous PrP in adjuvant can elicit immune (antibody) responses, suggesting that antigen processing of the PrP molecule can occur (25) .
CD8 and CD4 T cells generated during scrapie infection, under the experimental conditions used here, were unable to mount effector functions. Of interest, this inability to act as lytic agents or cytokine producers also occurred when scrapie was inoculated into PrP Ϫ/Ϫ mice with a deletion of the PrP gene as well as PrP Ϫ/Ϫ mice that were unable to transcribe PrP because of an engineered mutation. However, it may be possible using other immunizing strategies or vehicles to express prions (i.e., DNA vaccination) that at least scrapie-specific CD4 T-cell responses can be generated, since antibodies to prions can be made. As for scrapie-specific CD8 ϩ T cells, we mapped potential peptide motifs for MHC class I H-2 b and H-2 d molecules. Found were three CD8 T-cell motifs that bound well to K b (SC 50 , 3, 20, and 30 M) and one that bound to L d (SC 50 , 20 M) molecules. K b tetramers made with these three mPrP peptides-aa 2 to 9, aa 152 to 160, and aa 232 to 241-bound, albeit to a modest extent, to splenic lymphocytes at days 7, 50, and 71 after scrapie inoculation. However, these lymphocytes from PrP ϩ/ϩ mice were unable to synthesize the intracellular cytokines IFN-␥ or TNF-␣ when stimulated with appropriate peptides and were unable to lyse 51 chromiumlabeled PrP Ϫ/Ϫ MEF coated with mPrP peptides. These findings are reminiscent of those from recent studies of CD4 Ϫ/Ϫ mice infected with LCMV (47) and from a report characterizing circulating T cells for tumor-specific antigens (27) . Lastly, the accumulation of T cells in the brains of scrapie-infected mice likely mirrors other models in which T cells accumulated and resided in the CNS following antigen-specific stimulation, when the recognized antigen was continuously expressed in the brain (15, 18) and/or when attracted by chemokines expressed in the CNS (3, 39, 46) . Further analysis of these T cells and their induced genetic profiles should be of interest.
